CVR Partners saw its IBD SmartSelect Composite Rating jump to 96 Monday, up from 92 the day before.
Looking For The Best Stocks To Buy And Watch? Start Here
The revised score means the stock currently tops 96% of all other stocks in terms of key performance metrics and technical strength. The market's biggest winners often have a 95 or higher score in the early stages of a new price run, so that's a good starting point when looking for the best stocks to buy and watch.
CVR Partners is currently about 3% above a 93.73 entry from a flat base. Understand that it's a thinly traded stock, with average daily dollar volume under $8 million. Less liquid stocks are more prone to volatile action since it takes fewer shares traded to move the share price significantly.
The stock sports a 95 EPS Rating, which means its recent quarterly and longer-term annual earnings growth tops 95% of all stocks.
Its Accumulation/Distribution Rating of A- shows heavy buying by institutional investors, such as mutual funds and pension funds, over the last 13 weeks.
The company reported a 48% increase in earnings for Q2. Top line growth increased 27%, up from 12% in the prior report. The company has now posted accelerating growth in each of the last five quarters.
CVR Partners earns the No. 1 rank among its peers in the Chemicals-Agriculture industry group. CF Industries Holdings and Intrepid Potash are also among the group's highest-rated stocks.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
